MASLD Associated With 2-Fold Increase of Serious Bacterial Infection

Metabolic dysfunction-associated steatotic liver disease (MASLD) significantly increases the risk of severe infection, suggests a review of the current literature, which highlights a two-fold increased risk of serious bacterial infection (SBI) resulting in complications, such as hospitalization.¹

Researchers of the narrative review, publishing their findings in Liver International, highlighted the importance of their study, noting that SBI is among the least studied complications of MASLD, which affects more than 1 in 3 adults across the globe. The advanced stage of MASLD is metabolic dysfunction-associated steatohepatitis (MASH). Data also point to an increased risk of non-bacterial infections among patients with MASLD.